Literature DB >> 17458694

Detection of the CHEK2 1100delC mutation by MLPA BRCA1/2 analysis: a worthwhile strategy for its clinical applicability in 1100delC low-frequency populations?

Sara Gutiérrez-Enríquez, Judith Balmaña, Montserrat Baiget, Orland Díez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17458694     DOI： 10.1007/s10549-007-9555-2

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  5 in total

1.  CHEK2 c.1100delC mutation among non-BRCA1/2 Spanish hereditary breast cancer families.

Authors:  L Fachal; M Santamariña; A Blanco; A Carracedo; A Vega
Journal:  Clin Transl Oncol       Date:  2012-11-13       Impact factor: 3.405

2.  Comprehensive BRCA1 and BRCA2 mutation analyses and review of French Canadian families with at least three cases of breast cancer.

Authors:  Luca Cavallone; Suzanna L Arcand; Christine M Maugard; Serge Nolet; Louis A Gaboury; Anne-Marie Mes-Masson; Parviz Ghadirian; Diane Provencher; Patricia N Tonin
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

3.  Analysis of BRCA1/BRCA2 genes' contribution to breast cancer susceptibility in high risk Jewish Ashkenazi women.

Authors:  Tal Distelman-Menachem; Tal Shapira; Yael Laitman; Bella Kaufman; Frida Barak; Sean Tavtigian; Eitan Friedman
Journal:  Fam Cancer       Date:  2008-09-17       Impact factor: 2.375

Review 4.  CHEK2 (∗) 1100delC Mutation and Risk of Prostate Cancer.

Authors:  Victoria Hale; Maren Weischer; Jong Y Park
Journal:  Prostate Cancer       Date:  2014-11-06

5.  The CHEK2 1100delC allelic variant is not present in familial and sporadic breast cancer cases from Moroccan population.

Authors:  Chaymaa Marouf; Omar Hajji; Brehima Diakité; Amal Tazzite; Hassan Jouhadi; Abdellatif Benider; Sellama Nadifi
Journal:  Springerplus       Date:  2015-02-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.